Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting today.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Bruker
Symbol: BRKR
Recent BRKR Stock Price: $58.06
Average Analyst Price Target: n/a (36.63%)
BRKR Market Cap: $9.01B
Expected Ex-Dividend Date for BRKR stock: Aug 31 2022
Expected Payment Date for BRKR stock: Sep 16 2022
Expected Dividend & Yield for BRKR stock: 0.30%
Recent Analyst Action: Patrick B, analyst at Citigroup, reiterates coverage on Bruker (BRKR) stock in the Healthcare sector with a Buy rating and a price target of $ 80 (4 days ago).
TipRanks.com also reports that Bruker stock currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $79.33 . The target pricing ranges from a high forecast of $80.00 down to a low forecast of $78.00. Bruker (BRKR)’s last closing stock price was $58.06 which would put the average price target at 36.63% upside.Here are 3rd party ratings for BRKR stock:
- TipRanks.com: Strong Buy
- TradingView.com: n/a
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 36% (91 out of 252)
--------------------------------------------------------------------------
McKesson
Symbol: MCK
Recent MCK Stock Price: $356.79
Average Analyst Price Target: $391.38 (9.69%)
MCK Market Cap: $52.73B
Expected Ex-Dividend Date for MCK stock: Aug 31 2022
Expected Payment Date for MCK stock: Oct 03 2022
Expected Dividend & Yield for MCK stock: 0.52%
Recent Analyst Action: Ricky Goldwasser, analyst at Morgan Stanley, reiterates coverage on McKesson (MCK) stock in the Healthcare sector with a Buy rating and a price target of $ 403 (4 days ago).
TipRanks.com also reports that McKesson stock currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $391.38 . The target pricing ranges from a high forecast of $414.00 down to a low forecast of $345.00. McKesson (MCK)’s last closing stock price was $356.79 which would put the average price target at 9.69% upside.Here are 3rd party ratings for MCK stock:
- TipRanks.com: Strong Buy
- TradingView.com: n/a
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Buy, Bottom 35% (165 out of 252)
--------------------------------------------------------------------------
Premier
Symbol: PINC
Recent PINC Stock Price: $36.65
Average Analyst Price Target: $42.57 (16.15%)
PINC Market Cap: $4.40B
Expected Ex-Dividend Date for PINC stock: Aug 31 2022
Expected Payment Date for PINC stock: Sep 15 2022
Expected Dividend & Yield for PINC stock: 2.17%
Recent Analyst Action: Bill Sutherland, analyst at Benchmark Co., reiterates coverage on Premier (PINC) stock in the Healthcare sector with a Buy rating and a price target of $ 46 (2 days ago).
TipRanks.com also reports that Premier stock currently has 7 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $42.57 . The target pricing ranges from a high forecast of $46.00 down to a low forecast of $38.00. Premier (PINC)’s last closing stock price was $36.65 which would put the average price target at 16.15% upside.Here are 3rd party ratings for PINC stock:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Bottom 46% (135 out of 252)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
